Product Images Ctexli
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 3 images provide visual information about the product associated with Ctexli NDC 79378-310 by Mirum Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Chenodiol chemical structure - image 01
Figure 1: Mean (SE) of Observed Plasma Cholestanol by Treatment Sequence (All Randomized Patients) - image 02
This description appears to be a table related to a study or experiment, possibly involving a substance called "Cholestanol". The data seems to include measurements in micrograms per milliliter (ug/mL) and different time points or treatment groups denoted as "Run-in Open Label CTEXLI", "DB1" and "DB2". Various dates and numbers are listed under headings such as "Treatment", "Day of Visit", and "Placeto". The purpose and context of this table may be related to testing the effects or levels of Piasma Cholestanol in a study setting.*
Ctexli 250 mg tablets bottle label - image 03
This text provides information about a medication tablet, its dosage (250 mg), storage instructions (20°C to 25°C), and manufacturer details of Mirum Pharmaceuticals in Foster City, CA. The tablet is identified by its NDC (National Drug Code) code: 79378-310-90, and it is a prescription-only medication containing chenodiol. The lot number is X000 and the expiration date is indicated as YYYY-MM.DD. The tablet belongs to a batch of 1100 tablets. The QR code on the packaging suggests it may have additional information. Please note that the imprint area ranges from 1.0000" to 2.0000".*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
